NEW YORK (360Dx) – After a rough ending to 2018, shares of many diagnostics firms rebounded in January as the 360Dx Index ticked up 12 percent month over month.
The index's rebound reversed a soft December when it was down 12 percent from the prior month. Of the 27 companies in the index, just four saw their stock prices decline last month. The index beat the Dow Jones Industrial Average, which was up 7 percent month over month and the Nasdaq Biotech Index, which improved 10 percent. It lagged the Nasdaq Composite, which grew 13 percent.